These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20668031)

  • 1. Urocortin 2 lowers blood pressure and reduces plasma catecholamine levels in mice with hyperadrenergic activity.
    Gu Y; Zhang K; Biswas N; Friese RS; Lin DH; Mahata SK; Hoshijima M; O'Connor DT; Peterson KL; Brar BK
    Endocrinology; 2010 Oct; 151(10):4820-9. PubMed ID: 20668031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses.
    Vaingankar SM; Li Y; Biswas N; Gayen J; Choksi S; Rao F; Ziegler MG; Mahata SK; O'Connor DT
    J Hypertens; 2010 Apr; 28(4):817-25. PubMed ID: 20139771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice overexpressing chromogranin A display hypergranulogenic adrenal glands with attenuated ATP levels contributing to the hypertensive phenotype.
    Mir SA; Li Y; Story JD; Bal S; Awdishu L; Street AA; Mehta RL; Singh P; Vaingankar SM
    J Hypertens; 2018 May; 36(5):1115-1128. PubMed ID: 29389743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
    Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
    Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.
    Gayen JR; Gu Y; O'Connor DT; Mahata SK
    Endocrinology; 2009 Nov; 150(11):5027-35. PubMed ID: 19819970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene.
    Gayen JR; Zhang K; RamachandraRao SP; Mahata M; Chen Y; Kim HS; Naviaux RK; Sharma K; Mahata SK; O'Connor DT
    Circ Cardiovasc Genet; 2010 Oct; 3(5):414-25. PubMed ID: 20729505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors.
    Yakabi K; Noguchi M; Ohno S; Ro S; Onouchi T; Ochiai M; Takabayashi H; Takayama K; Harada Y; Sadakane C; Hattori T
    Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E72-82. PubMed ID: 21540451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion.
    Chen Y; Rao F; Rodriguez-Flores JL; Mahata M; Fung MM; Stridsberg M; Vaingankar SM; Wen G; Salem RM; Das M; Cockburn MG; Schork NJ; Ziegler MG; Hamilton BA; Mahata SK; Taupenot L; O'Connor DT
    J Am Coll Cardiol; 2008 Oct; 52(18):1468-81. PubMed ID: 19017515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin 2 induces tyrosine hydroxylase phosphorylation in PC12 cells.
    Nemoto T; Mano-Otagiri A; Shibasaki T
    Biochem Biophys Res Commun; 2005 May; 330(3):821-31. PubMed ID: 15809070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long human CHGA flanking chromosome 14 sequence required for optimal BAC transgenic "rescue" of disease phenotypes in the mouse Chga knockout.
    Vaingankar SM; Li Y; Corti A; Biswas N; Gayen J; O'Connor DT; Mahata SK
    Physiol Genomics; 2010 Mar; 41(1):91-101. PubMed ID: 20009010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.
    Pasqua T; Mahata S; Bandyopadhyay GK; Biswas A; Perkins GA; Sinha-Hikim AP; Goldstein DS; Eiden LE; Mahata SK
    Cell Tissue Res; 2016 Mar; 363(3):693-712. PubMed ID: 26572539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A: a surprising link between granule biogenesis and hypertension.
    Kim T; Loh YP
    J Clin Invest; 2005 Jul; 115(7):1711-3. PubMed ID: 16007250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension.
    Friese RS; Altshuler AE; Zhang K; Miramontes-Gonzalez JP; Hightower CM; Jirout ML; Salem RM; Gayen JR; Mahapatra NR; Biswas N; Cale M; Vaingankar SM; Kim HS; Courel M; Taupenot L; Ziegler MG; Schork NJ; Pravenec M; Mahata SK; Schmid-Schönbein GW; O'Connor DT
    Hum Mol Genet; 2013 Sep; 22(18):3624-40. PubMed ID: 23674521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac electrical activity in a genomically "humanized" chromogranin a monogenic mouse model with hyperadrenergic hypertension.
    Dev NB; Mir SA; Gayen JR; Siddiqui JA; Mustapic M; Vaingankar SM
    J Cardiovasc Transl Res; 2014 Jul; 7(5):483-493. PubMed ID: 24821335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.
    Mahapatra NR; O'Connor DT; Vaingankar SM; Hikim AP; Mahata M; Ray S; Staite E; Wu H; Gu Y; Dalton N; Kennedy BP; Ziegler MG; Ross J; Mahata SK
    J Clin Invest; 2005 Jul; 115(7):1942-52. PubMed ID: 16007257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation contributes to urocortin-enhanced midbrain dopaminergic neuron differentiation.
    Huang HY; Chiu TL; Chang HF; Hsu HR; Pang CY; Liew HK; Wang MJ
    Stem Cells; 2015 May; 33(5):1601-17. PubMed ID: 25641682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
    Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
    Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.
    Chen A; Blount A; Vaughan J; Brar B; Vale W
    Endocrinology; 2004 May; 145(5):2445-57. PubMed ID: 14736736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of tyrosine hydroxylase gene reveals functional interdependence of adrenocortical and chromaffin cell system in vivo.
    Bornstein SR; Tian H; Haidan A; Böttner A; Hiroi N; Eisenhofer G; McCann SM; Chrousos GP; Roffler-Tarlov S
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14742-7. PubMed ID: 11121073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of urocortin and corticotropin-releasing hormone receptors in the bovine adrenal gland.
    Squillacioti C; De Luca A; Liguori G; Paino S; Mirabella N
    Gen Comp Endocrinol; 2011 Jul; 172(3):416-22. PubMed ID: 21504748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.